Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks
Status:
Withdrawn
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to improve port wine stain therapeutic outcome in response to
laser therapy. The researcher want to determine whether the combined use of pulsed dye laser
therapy and topical ranibizumab will improve port wine stain therapeutic outcome.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, Irvine
Collaborator:
Beckman Laser Institute University of California Irvine